30 Days, 30 Stories Recap
July 07, 2014 |
As we mark the close of the second annual Cancer Immunotherapy Month this June, we hope you had the chance to view at least some of the inspiring stories from patients and caregivers published on CRI’s new patient-oriented immunotherapy website, TheAnswerToCancer.org.
Each day in the month of June, we unveiled a new story of courage and survival, demonstrating the power of immunotherapy to change fate and instill hope. These stories provide an up-close look at the different types of immunotherapy available today, and convey in patients’ own words the experience of receiving treatment. If you didn’t get a chance to catch the campaign, or if you a missed a few days, we encourage you to revisit the site today.
Among the many powerful stories told was that of Pam G., treated with the drug nivolumab, who saw her stage 4 lung cancer melt away in just months; Carley R., a sophomore in college who is one of the most eloquent advocates of immunotherapy you’ll ever meet; Helena B., who traveled from her native Colombia to Switzerland to save her leg from amputation and later took up the tango; Kevin L., who used his time receiving interferon for melanoma to write his memoir; and Jesse C., who survived pancreatic cancer with the help of a cancer vaccine called GVAX.
These 30 stories are just the first installment of the many stories TheA2C will host in the coming years, as the site grows into a flourishing online community for patients and caregivers interested in learning which immunotherapy may be right for them or their loved ones. We encourage you to submit your own stories and keep coming back to the site to watch it grow.
Lastly, I would like to take this opportunity to personally thank all the patients who agreed to share their stories with us—over the phone and in person—in order that we could share them with others. There is no better testimony to the power of immunotherapy to change lives than the words of patients themselves. From everyone at CRI, we sincerely thank you.